Biocentric Energy Holdings, Inc. (BEHL)

[jbsliverer]

You may be on to something there. There has been several studies to use docosahexaenoic acid (DHA), polyunsaturated fatty acids, and Omega 3 ethel esters derived from algae. Why am I writing words that I can't pronounce is this. Drugs like Lovaza are used to lower high levels of triacylglycerol (TAG) in adults that suffer from high hypertriglyceridemia with the omega-3-acid ethyl esters processed from fish oils.

A couple of the studies on algae derived DHA triglyceride oil or algal-DHA was published just last year and was getting some very good results.
http://www.ncbi.nlm.nih.gov/pubmed/19145206

http://resources.metapress.com/pdf-preview.axd?code=p573lm3uut70h708&size=largest

But I'm a little confused and not quite understanding is how using a triglyceride lowers triglycerides in the body. Not a chemist, but might be the bonding that algae cells are doing with it and keeping it away from our system. Just learning more about it myself and maybe someone else can explain.

To match this though and as I understand the process, it is the triglycerides that we extract from inside the algae cells and convert that oil to biofuels and it is that process that gives the most impediment for commercialization against regular oil costs.

But when it comes to drug costs, it seems to me that very well the same process would be quite effective and cost savings. I believe that since it is already quite proven with endless studies and applications for omega-3 benefits to the cardiovascular system, that all we are needing is time for recognition on algae omega-3. That time is been happening now IMO and we will see it in the near future.